HNGE HNGE Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

Globus MedicalGMED

——

Revenue$182.3M+47.2%

Gross profit$154.2M+53.9%

Operating income$32.1M+144%

Net income$35.1M+105%

EPS (diluted)$0.41-68.7%

Cash & equivalents$188.1M-35.2%

Total debt$7.0M—

Total equity$111.7M+136%

Total assets$728.8M—

Operating cash flow$43.1M+775%

CapEx$83.0K+62.7%

Free cash flow$43.0M+782%

Market cap$5.37B—

Enterprise value$5.19B—

P/S8.3×—

Gross margin80.8%+1.5pp

Operating margin-85.8%—

Net margin-83.9%—

FCF margin32.3%—

Return on equity551.8%—

Debt / equity0.1×—

Current ratio1.3×—

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is HNGE's share based compensation arrangement by share based payment award options exercisable number?: HNGE (HNGE) reported share based compensation arrangement by share based payment award options exercisable number of $1.08M in Q1 2026.